Henry Schein Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 3/2/2026)
| Balance Sheet | Total Assets | 11,215,000,000.00 | ROE | 28.93 % |
| Balance Sheet | Total Equity | 3,245,000,000.00 | ROA | 3.55 % |
| Cashflow | Capital Expenditures | -139,000,000.00 | P/FCF | 18.17 |
| Cashflow | Free Cash Flow | 573,000,000.00 | – | – |
| Cashflow | Operating Cash Flow | 712,000,000.00 | P/CF | 14.63 |
| Income | Earnings per Share (diluted) | 3.27 | Div. Yield | – |
| Income | Net Income | 398,000,000.00 | P/E | 26.17 |
| Income | Shares Outstanding | 121,718,000.00 | P/B | 3.21 |
| Income | Total Revenue | 13,184,000,000.00 | P/S | 0.79 |
Ratios calculated on: 10/14/2026
Company Description
Henry Schein, Inc. is a provider of health care products and services to office-based practitioners. The Company conducts its business through two segments: healthcare distribution and technology. The healthcare distribution segment aggregates its dental, medical, animal health and international operating segments. This segment consists of consumable products, small equipment, laboratory products, large dental equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. Its technology group provides software, technology and other services to healthcare practitioners, primarily in the United States, Canada, the United Kingdom, Australia and New Zealand. In July 2013, Henry Schein Inc divested an unprofitable non controlling stake in a dental wholesale business in the Middle East.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.henryschein.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more